Caffeine and adenosine A2a receptor antagonists prevent β-amyloid (25–35)-induced cognitive deficits in mice

Experimental Neurology - Tập 203 - Trang 241-245 - 2007
Oscar P. Dall'Igna1, Paulo Fett1, Marcio W. Gomes1, Diogo O. Souza1, Rodrigo A. Cunha2, Diogo R. Lara3
1Departamento de Bioquímica, ICBS, UFRGS, Porto Alegre, Brazil
2Centro de Neurociências de Coimbra, Instituto de Bioquímica, Faculdade de Medicina, Universidade de Coimbra, Portugal
3Departamento de Ciências Fisiológicas, Faculdade de Biociências, Pontifícia Universidade Católica do Rio Grande do Sul, Porto Alegre, Brazil

Tài liệu tham khảo

Angelucci, 1999, The effect of caffeine in animal models of learning and memory, Eur. J. Pharmacol., 373, 135, 10.1016/S0014-2999(99)00225-3 Angulo, 2003, A1 adenosine receptors accumulate in neurodegenerative structures in Alzheimer disease and mediate both amyloid precursor protein processing and tau phosphorylation and translocation, Brain Pathol., 13, 440, 10.1111/j.1750-3639.2003.tb00475.x Ciruela, 2006, Presynaptic control of striatal glutamatergic neurotransmission by adenosine A1–A2A receptor heteromers, J. Neurosci., 26, 2080, 10.1523/JNEUROSCI.3574-05.2006 Coleman, 2004, A focus on the synapse for neuroprotection in Alzheimer disease and other dementias, Neurology, 63, 1155, 10.1212/01.WNL.0000140626.48118.0A Cunha, 2005, Neuroprotection by adenosine in the brain: from A1 receptor activation to A2A receptor blockade, Purinergic Signal., 1, 111, 10.1007/s11302-005-0649-1 Dall'Igna, 2003, Neuroprotection by caffeine and adenosine A2A receptor blockade of β-amyloid neurotoxicity, Br. J. Pharmacol., 138, 1207, 10.1038/sj.bjp.0705185 Dall'Igna, 2004, β-amyloid treatment sensitizes mice to amphetamine-induced locomotion but reduces response to caffeine, Neurodegener. Dis., 1, 38, 10.1159/000076668 de Oliveira, 2005, Effect of subchronic caffeine treatment on MK-801-induced changes in locomotion, cognition and ataxia in mice, Behav. Pharmacol., 16, 79, 10.1097/00008877-200503000-00002 Fredholm, 1999, Actions of caffeine in the brain with special reference to factors that contribute to its widespread use, Pharmacol. Rev., 51, 83 Hardy, 2002, The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics, Science, 297, 353, 10.1126/science.1072994 Harkany, 1999, Neuroprotective approaches in experimental models of β-amyloid neurotoxicity: relevance to Alzheimer's disease, Prog. Neuro-Psychopharmacol. Biol. Psychiatry, 23, 963, 10.1016/S0278-5846(99)00058-5 Hughes, 2004, The value of spontaneous alteration behavior (SAB) as a test of retention in pharmacological investigations of memory, Neurosci. Behav. Rev., 28, 497, 10.1016/j.neubiorev.2004.06.006 Johnson-Kozlow, 2002, Coffee consumption and cognitive function among older adults, Am. J. Epidemiol., 156, 842, 10.1093/aje/kwf119 Karcz-Kubicha, 2003, Involvement of adenosine A1 and A2A receptors in the motor effects of caffeine after its acute and chronic administration, Neuropsychopharmacology, 28, 1281, 10.1038/sj.npp.1300167 Kazlauckas, 2005, Behavioral and cognitive profile of mice with high and low exploratory phenotypes, Behav. Brain Res., 162, 272, 10.1016/j.bbr.2005.03.021 Klein, 2004, Small assemblies of unmodified amyloid β-protein are the proximate neurotoxin in Alzheimer's disease, Neurobiol. Aging, 25, 569, 10.1016/j.neurobiolaging.2004.02.010 Kopf, 1999, Adenosine and memory storage: effects of A1 and A2 receptor antagonists, Psychopharmacology, 146, 214, 10.1007/s002130051109 Maia, 2002, Does caffeine intake protect from Alzheimer's disease?, Eur J. Neurol., 9, 377, 10.1046/j.1468-1331.2002.00421.x Maurice, 1996, Amnesia induced in mice by centrally administered beta-amyloid peptides involves cholinergic dysfunction, Brain Res., 706, 181, 10.1016/0006-8993(95)01032-7 Paxinos, 2001 Prediger, 2005, Caffeine reverses age-related deficits in olfactory discrimination and social recognition memory in rats. Involvement of adenosine A1 and A2A receptors, Neurobiol. Aging, 26, 957, 10.1016/j.neurobiolaging.2004.08.012 Quarta, 2004, Opposite modulatory roles for adenosine A1 and A2A receptors on glutamate and dopamine release in the shell of the nucleus accumbens. Effects of chronic caffeine exposure, J. Neurochem., 88, 1151, 10.1046/j.1471-4159.2003.02245.x Rebola, 2003, Enhanced adenosine A2A receptor facilitation of synaptic transmission in the hippocampus of aged rats, J. Neurophysiol., 90, 1295, 10.1152/jn.00896.2002 Rebola, 2005, Different synaptic and subsynaptic localization of adenosine A2A receptors in the hippocampus and striatum of the rat, Neuroscience, 132, 893, 10.1016/j.neuroscience.2005.01.014 Saura, 2005, Adenosine A2A receptor stimulation potentiates nitric oxide release by activated microglia, J. Neurochem., 95, 919, 10.1111/j.1471-4159.2005.03395.x Solinas, 2002, Caffeine induces dopamine and glutamate release in the shell of the nucleus accumbens, J. Neurosci., 22, 6321, 10.1523/JNEUROSCI.22-15-06321.2002 Svenningsson, 1997, Antagonism of adenosine A2A receptors underlies the behavioural activating effect of caffeine and is associated with reduced expression of messenger RNA for NGFI-A and NGFI-B in caudate–putamen and nucleus accumbens, Neuroscience, 79, 753, 10.1016/S0306-4522(97)00046-8 Xu, 2002, Caffeine's neuroprotection against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine toxicity shows no tolerance to chronic caffeine administration in mice, Neurosci. Lett., 322, 13, 10.1016/S0304-3940(02)00069-1